{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "R",
          "alt": "P",
          "position": "68"
        },
        "variant_string_id": "PINK1 R68P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the gene encoding PINK1 have been associated with the loss of dopaminergic neurons characteristic of familial and sporadic Parkinson disease.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as the loss of dopaminergic neurons, which is relevant to the functional assays described."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The in vitro system of stable human dopaminergic neuronal cell lines coexpressing an equivalent copy of normal and mutant PINK1 simulates ‘‘heterozygous’’ and ‘‘homozygous’’ states in patients.",
          "judgment": "Yes",
          "reasoning": "The assay effectively models the disease pathogenesis by simulating the heterozygous and homozygous states, which is relevant to Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Cell lines expressing p.R68P did not show a significant difference in apoptosis or change in DCm compared to wild-type PINK1 when subjected to oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The assay was performed with appropriate controls and conditions to assess the effect of the p.R68P variant on apoptosis and mitochondrial membrane potential under oxidative stress."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Cell lines expressing p.R68P did not show a significant difference in apoptosis or change in DCm compared to wild-type PINK1 when subjected to oxidative stress.",
          "judgment": "No",
          "reasoning": "The functional data does not support a pathogenic effect for the p.R68P variant, as it did not exhibit significant differences from wild-type under the tested conditions."
        }
      ],
      "final_evidence_strength": {
        "type": "Benign",
        "strength": "N/A"
      },
      "overall_conclusion": "The p.R68P variant did not show significant differences in apoptosis or change in mitochondrial membrane potential compared to wild-type PINK1 under oxidative stress, suggesting no pathogenic effect based on the functional assays performed."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "E",
          "alt": "G",
          "position": "231"
        },
        "variant_string_id": "PINK1 E231G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the gene encoding PINK1 have been associated with the loss of dopaminergic neurons characteristic of familial and sporadic Parkinson disease.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as the loss of dopaminergic neurons, which is relevant to the functional assays described."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The in vitro system of stable human dopaminergic neuronal cell lines coexpressing an equivalent copy of normal and mutant PINK1 simulates ‘‘heterozygous’’ and ‘‘homozygous’’ states in patients.",
          "judgment": "Yes",
          "reasoning": "The assay effectively models the disease pathogenesis by simulating the heterozygous and homozygous states, which is relevant to Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Cell lines expressing p.E231G exhibited a greater rate of apoptosis and decrease in DCm under oxidative stress compared to wild-type.",
          "judgment": "Yes",
          "reasoning": "The assay was performed with appropriate controls and conditions to assess the effect of the p.E231G variant on apoptosis and mitochondrial membrane potential under oxidative stress."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Cell lines expressing p.E231G exhibited a greater rate of apoptosis and decrease in DCm under oxidative stress compared to wild-type.",
          "judgment": "Yes",
          "reasoning": "The functional data supports a pathogenic effect for the p.E231G variant, as it exhibited significant differences from wild-type under the tested conditions."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The p.E231G variant showed a significant increase in apoptosis and decrease in mitochondrial membrane potential compared to wild-type PINK1 under oxidative stress, suggesting a pathogenic effect based on the functional assays performed."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "339"
        },
        "variant_string_id": "PINK1 A339T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the gene encoding PINK1 have been associated with the loss of dopaminergic neurons characteristic of familial and sporadic Parkinson disease.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as the loss of dopaminergic neurons, which is relevant to the functional assays described."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The in vitro system of stable human dopaminergic neuronal cell lines coexpressing an equivalent copy of normal and mutant PINK1 simulates ‘‘heterozygous’’ and ‘‘homozygous’’ states in patients.",
          "judgment": "Yes",
          "reasoning": "The assay effectively models the disease pathogenesis by simulating the heterozygous and homozygous states, which is relevant to Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Cell lines expressing p.A339T exhibited a greater rate of apoptosis and decrease in DCm under oxidative stress compared to wild-type.",
          "judgment": "Yes",
          "reasoning": "The assay was performed with appropriate controls and conditions to assess the effect of the p.A339T variant on apoptosis and mitochondrial membrane potential under oxidative stress."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Cell lines expressing p.A339T exhibited a greater rate of apoptosis and decrease in DCm under oxidative stress compared to wild-type.",
          "judgment": "Yes",
          "reasoning": "The functional data supports a pathogenic effect for the p.A339T variant, as it exhibited significant differences from wild-type under the tested conditions."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The p.A339T variant showed a significant increase in apoptosis and decrease in mitochondrial membrane potential compared to wild-type PINK1 under oxidative stress, suggesting a pathogenic effect based on the functional assays performed."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "442"
        },
        "variant_string_id": "PINK1 I442T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the gene encoding PINK1 have been associated with the loss of dopaminergic neurons characteristic of familial and sporadic Parkinson disease.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as the loss of dopaminergic neurons, which is relevant to the functional assays described."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The in vitro system of stable human dopaminergic neuronal cell lines coexpressing an equivalent copy of normal and mutant PINK1 simulates ‘‘heterozygous’’ and ‘‘homozygous’’ states in patients.",
          "judgment": "Yes",
          "reasoning": "The assay effectively models the disease pathogenesis by simulating the heterozygous and homozygous states, which is relevant to Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Cell lines expressing p.I442T exhibited a greater rate of apoptosis and decrease in DCm under oxidative stress compared to wild-type.",
          "judgment": "Yes",
          "reasoning": "The assay was performed with appropriate controls and conditions to assess the effect of the p.I442T variant on apoptosis and mitochondrial membrane potential under oxidative stress."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Cell lines expressing p.I442T exhibited a greater rate of apoptosis and decrease in DCm under oxidative stress compared to wild-type.",
          "judgment": "Yes",
          "reasoning": "The functional data supports a pathogenic effect for the p.I442T variant, as it exhibited significant differences from wild-type under the tested conditions."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The p.I442T variant showed a significant increase in apoptosis and decrease in mitochondrial membrane potential compared to wild-type PINK1 under oxidative stress, suggesting a pathogenic effect based on the functional assays performed."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "D",
          "alt": "N",
          "position": "525"
        },
        "variant_string_id": "PINK1 D525N"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the gene encoding PINK1 have been associated with the loss of dopaminergic neurons characteristic of familial and sporadic Parkinson disease.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as the loss of dopaminergic neurons, which is relevant to the functional assays described."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The in vitro system of stable human dopaminergic neuronal cell lines coexpressing an equivalent copy of normal and mutant PINK1 simulates ‘‘heterozygous’’ and ‘‘homozygous’’ states in patients.",
          "judgment": "Yes",
          "reasoning": "The assay effectively models the disease pathogenesis by simulating the heterozygous and homozygous states, which is relevant to Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Cell lines expressing p.D525N exhibited a greater rate of apoptosis and decrease in DCm under oxidative stress compared to wild-type.",
          "judgment": "Yes",
          "reasoning": "The assay was performed with appropriate controls and conditions to assess the effect of the p.D525N variant on apoptosis and mitochondrial membrane potential under oxidative stress."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Cell lines expressing p.D525N exhibited a greater rate of apoptosis and decrease in DCm under oxidative stress compared to wild-type.",
          "judgment": "Yes",
          "reasoning": "The functional data supports a pathogenic effect for the p.D525N variant, as it exhibited significant differences from wild-type under the tested conditions."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The p.D525N variant showed a significant increase in apoptosis and decrease in mitochondrial membrane potential compared to wild-type PINK1 under oxidative stress, suggesting a pathogenic effect based on the functional assays performed."
    }
  ]
}